Managing Cannabinoid Hyperemesis Syndrome - 20/05/26
, Michael Shalaby, MD b, Kendra A. Gage, PharmD c, Michael Gottlieb, MD dKeywords : Cannabinoid hyperemesis syndrome, Cannabinoid, Hyperemesis, Vomiting
Plan
| Supervising editor : Gillian R. Schmitz, MD. Specific detailed information about possible conflict of interest for individual editors is available at editors . |
|
| All authors attest to meeting the four ICMJE.org authorship criteria:(1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. |
|
| Funding and support: By Annals’ policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org ). The authors have stated that no such relationships exist. This work was supported by the United States Department of Veterans Affairs Health Systems. The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of the VA or of the US Government. |
|
| Continuing Medical Education exam for this article is available at ACEPeCME/ . |
Vol 87 - N° 6
P. 717-722 - juin 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
